Naloxegol
id:
naloxegol-313-8261397
title:
Naloxegol
text:
Naloxegol is a peripherally acting μ-opioid receptor antagonist developed by AstraZeneca, licensed from Nektar Therapeutics, for the treatment of opioid-induced constipation. It was approved in 2014 in adult patients with chronic, non-cancer pain. Doses of 25 mg were found safe and well tolerated for 52 weeks. When given concomitantly with opioid analgesics, naloxegol reduced constipation-related side effects, while maintaining comparable levels of analgesia. The most common side effects are abd
brand slug:
wiki
category slug:
encyclopedia
description:
Medication used in the treatment for Opioid-Induced Constipation
original url:
https://en.wikipedia.org/wiki/Naloxegol
date created:
date modified:
2024-04-07T06:30:29Z
main entity:
{"identifier":"Q15708351","url":"https://www.wikidata.org/entity/Q15708351"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/8/8e/Naloxegol.svg","width":512,"height":321}
fields total:
13
integrity:
15